NXGN.M (NXGN.M)
TASE TASE Primary Summary
NXGN.M (NXGN.M) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has NXGN.M ever had a stock split?
NXGN.M Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Harel Hershtik CEO | TASE Exchange | - ISIN |
| Il Country | 5 Employees | - Last Dividend | 3 Sep 2023 Last Split | - IPO Date |
Overview
Nextgen Biomed Ltd is a pioneering firm based in Tel Aviv, Israel, focused on the development of innovative topical treatments for psoriasis. Initially established in 1990 as Sela Group.Com Ltd., the company underwent a significant rebranding in February 2010, changing its name to Nextgen Biomed Ltd. This rebranding marked a milestone in the company's dedication to advancing biotechnological research and development for the betterment of individuals suffering from skin conditions, notably psoriasis. With decades of experience and a firm foundation in the biotech industry, Nextgen Biomed Ltd continues to push the boundaries of medical science, working towards novel therapeutic solutions.
Products and Services
Nextgen Biomed Ltd specializes in the development of a range of topical treatments aimed at addressing the complex challenges of psoriasis, a chronic skin condition that affects millions worldwide. Among its innovative solutions are:
- Advanced Topical Psoriasis Treatments: These are specially formulated creams or ointments designed to reduce the symptoms of psoriasis, such as itching, inflammation, and the formation of scaly skin patches. Leveraging cutting-edge research, these treatments aim to offer both relief and improvement in skin condition for patients.
